Funding

Cutting-Edge Basic Research Awards (CEBRA) (R21 Clinical Trial Optional)

Funder
National Institutes of Health
Opportunity type
Grant
Call status
Open
Opens
2025-02-10
Deadline
2027-03-10
View opportunity

Overview

Supports high-risk, potentially transformative basic research on substance use disorders. Projects should test unconventional hypotheses or develop substantially new techniques where supporting evidence is limited and potential impact is high.

Funding amount

Up to USD 275,000 in direct costs over 2 years; maximum USD 150,000 per year

Eligibility

Wits may apply as a non-US higher education institution. Proposals must fit this call and the mission of a participating institute; institutional registrations and funder requirements apply.

Additional deadlines

Next application deadline, including permitted resubmissions: 10 March 2027. Submit by 17:00 local time of the applicant organisation. Call expiration: 12 August 2027. This is separate from the application deadline.

Contact
National Institutes of Health ยท grantsinfo@nih.gov
Official source
NIH / Grants.gov
Last checked
2026-09-19